Literature DB >> 26711782

MiR-130b inhibits proliferation and induces apoptosis of gastric cancer cells via CYLD.

Baoyou Sun1, Lei Li1, Wendong Ma1, Shikang Wang1, Chunjin Huang2.   

Abstract

A role of microRNA-130b (miR-130b) in the carcinogenesis of gastric cancer remains undetermined. In this study, we studied the effects and mechanism of miR-130b to the gastric cell proliferation and apoptosis. We found that the levels of miR-130b significantly up-regulated in gastric cancer tissue, compared to the paired adjacent non-tumor gastric tissue. The miR-130b levels in gastric cancer cell lines were significantly higher than those in control normal gastric tissues. Transfection with the miR-130b mimic enhanced the cell proliferation and suppressed cell apoptosis in gastric cancer cells, while transfection with the anti-sense of miR-130b (anti-miR-130b) suppressed cell proliferation and induced cell apoptosis in gastric cancer cells. Bioinformatics analyses showed that cylindromatosis gene (CYLD) was a potential target gene of miR-130b. The luciferase activity assay and western blot verified that miR-130b targeted CYLD messenger RNA (mRNA) to modulate its protein levels. Together, our study suggests that aberrantly expressed miR-130b may regulate cell apoptosis and proliferation of human gastric cancer cells via CYLD, which appears to be a promising therapeutic target for gastric cancer.

Entities:  

Keywords:  Apoptosis; CYLD; Gastric cancer; Proliferation; miR-130b

Mesh:

Substances:

Year:  2015        PMID: 26711782     DOI: 10.1007/s13277-015-4632-3

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  28 in total

1.  Over-expressing CYLD augments antitumor activity of TRAIL by inhibiting the NF-κB survival signaling in lung cancer cells.

Authors:  L L Deng; Y X Shao; H F Lv; H B Deng; F Z Lv
Journal:  Neoplasma       Date:  2012       Impact factor: 2.575

2.  FBXL5 inhibits metastasis of gastric cancer through suppressing Snail1.

Authors:  Weidong Wu; Honghua Ding; Jun Cao; Weihao Zhang
Journal:  Cell Physiol Biochem       Date:  2015-03-26

3.  Regulation of growth of human bladder cancer by miR-192.

Authors:  Yongchao Jin; Jiasun Lu; Jiling Wen; Yinzhou Shen; Xiaofei Wen
Journal:  Tumour Biol       Date:  2015-01-09

4.  MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.

Authors:  Hong-Liang Liang; Ai-Ping Hu; Sen-Lin Li; Jia-Ping Xie; Qing-Zhu Ma; Ji-Yong Liu
Journal:  Asian Pac J Cancer Prev       Date:  2015

5.  MiRNA-181c inhibits EGFR-signaling-dependent MMP9 activation via suppressing Akt phosphorylation in glioblastoma.

Authors:  Fei Wang; Weizhong Xiao; Jiyong Sun; Donghua Han; Youhou Zhu
Journal:  Tumour Biol       Date:  2014-05-28

6.  MiRNA-34a inhibits EGFR-signaling-dependent MMP7 activation in gastric cancer.

Authors:  Gang Liu; Chuanshen Jiang; Dazhou Li; Rong Wang; Wen Wang
Journal:  Tumour Biol       Date:  2014-07-01

7.  Phosphorylation of the tumor suppressor CYLD by the breast cancer oncogene IKKepsilon promotes cell transformation.

Authors:  Jessica E Hutti; Rhine R Shen; Derek W Abbott; Alicia Y Zhou; Kam M Sprott; John M Asara; William C Hahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2009-05-14       Impact factor: 17.970

8.  Functional studies of miR-130a on the inhibitory pathways of apoptosis in patients with chronic myeloid leukemia.

Authors:  X Zhu; H Zhao; Z Lin; G Zhang
Journal:  Cancer Gene Ther       Date:  2015-10-23       Impact factor: 5.987

9.  Tumor Suppressor Function of CYLD in Nonmelanoma Skin Cancer.

Authors:  K C Masoumi; Gina Shaw-Hallgren; Ramin Massoumi
Journal:  J Skin Cancer       Date:  2011-12-17

10.  MiR-143 inhibits EGFR-signaling-dependent osteosarcoma invasion.

Authors:  Qiang Wang; Jun Cai; Jingcheng Wang; Chuanzhi Xiong; Jianning Zhao
Journal:  Tumour Biol       Date:  2014-09-17
View more
  7 in total

1.  MicroRNA-130b functions as an oncogene and is a predictive marker of poor prognosis in lung adenocarcinoma.

Authors:  Yeseul Kim; Hyunsung Kim; Seongsik Bang; Seungyun Jee; Kiseok Jang
Journal:  Lab Invest       Date:  2020-09-30       Impact factor: 5.662

2.  MicroRNA-130b targets PTEN to mediate drug resistance and proliferation of breast cancer cells via the PI3K/Akt signaling pathway.

Authors:  Yuan Miao; Wei Zheng; Nana Li; Zhen Su; Lifen Zhao; Huimin Zhou; Li Jia
Journal:  Sci Rep       Date:  2017-02-06       Impact factor: 4.379

3.  MicroRNA-130b promotes cell migration and invasion by inhibiting peroxisome proliferator-activated receptor-γ in human glioma.

Authors:  Peidong Li; Xinjun Wang; Qiao Shan; Yuehui Wu; Zhen Wang
Journal:  Oncol Lett       Date:  2017-02-22       Impact factor: 2.967

4.  Gga-miR-130b-3p inhibits MSB1 cell proliferation, migration, invasion, and its downregulation in MD tumor is attributed to hypermethylation.

Authors:  Chunfang Zhao; Xin Li; Bo Han; Lujiang Qu; Changjun Liu; Jiuzhou Song; Ling Lian; Ning Yang
Journal:  Oncotarget       Date:  2018-05-11

5.  MiR130b from Schlafen4+ MDSCs stimulates epithelial proliferation and correlates with preneoplastic changes prior to gastric cancer.

Authors:  Lin Ding; Qian Li; Jayati Chakrabarti; Andres Munoz; Emmanuelle Faure-Kumar; Ramon Ocadiz-Ruiz; Nataliya Razumilava; Guiying Zhang; Michael H Hayes; Ricky A Sontz; Zoe Elena Mendoza; Swapna Mahurkar; Joel K Greenson; Guillermo Perez-Perez; Nguyen Thi Hong Hanh; Yana Zavros; Linda C Samuelson; Dimitrios Iliopoulos; Juanita L Merchant
Journal:  Gut       Date:  2020-01-24       Impact factor: 23.059

6.  MicroRNA-130b targets PTEN to induce resistance to cisplatin in lung cancer cells by activating Wnt/β-catenin pathway.

Authors:  Qiang Zhang; Bin Zhang; Leina Sun; Qingna Yan; Yu Zhang; Zhenfa Zhang; Yanjun Su; Changli Wang
Journal:  Cell Biochem Funct       Date:  2018-04-13       Impact factor: 3.685

Review 7.  The role of deubiquitinating enzymes in gastric cancer.

Authors:  Jiangang Sun; Xiaojing Shi; M A A Mamun; Yongshun Gao
Journal:  Oncol Lett       Date:  2019-11-07       Impact factor: 2.967

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.